Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Impact of Prothrombin Complex Concentrate on the Anticoagulatory Effects of Edoxaban

Trial Profile

The Impact of Prothrombin Complex Concentrate on the Anticoagulatory Effects of Edoxaban

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 16 Aug 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Edoxaban (Primary) ; Prothrombin complex concentrate
  • Indications Embolism; Stroke; Venous thromboembolism
  • Focus Pharmacodynamics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 16 Aug 2016 Results of this and two other studies published in the British Journal of Clinical Pharmacology.
    • 15 Apr 2014 New trial record
    • 29 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top